KYMR NASDAQ
Kymera Therapeutics, Inc.
1W: -4.6%
1M: -9.2%
3M: -7.8%
YTD: +10.8%
1Y: +156.4%
3Y: +177.8%
5Y: +77.1%
$78.89
-1.72 (-2.13%)
Weekly Expected Move ±5.0%
$74
$78
$82
$86
$90
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$51M
Revenue
-12.6% YoY
$-315M
Net Income
-30.8% YoY
$-244M
Free Cash Flow
-1.7% YoY
100.0%
Gross Margin
-244.9%
Op. Margin
-201.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-26.1%
ROA-23.2%
ROIC-34.9%
Valuation
P/E-24.4
P/B5.0
EV/EBITDA-24.0
Leverage
Debt/Equity0.05
Current Ratio10.47
Interest Cov.-1323.7x
Quality Scores
Piotroski F4/9
Altman Z29.00
Beneish M-2.84